Lakefront Biotherapeutics NV (GLPG) Form 6-K — Nov 2, 2026
Lakefront Biotherapeutics NV announced on November 2, 2026 the appointment of Dr. Mehdi Shahidi as Non-Executive Independent Director, effective immediately, by way of co-optation. Dr. Shahidi brings over 20 years of biopharma drug development experience, including roles as Head of Development and CMO at Ottimo Pharma, Venture Partner at Medicxi, and previously SVP, Global Head of Medicine and CMO at Boehringer Ingelheim.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.